However, there are conflicting reports regarding the expression of PKM2 and overall patient survival: some studies show that PKM2 expression is associated with worse overall survival of pancreatic cancer patients [20, 24, 25], while others show improved overall survival [26], and still others show no effect on overall survival [27, 28]. The gene discussed is PKM; the disease is pancreatic neoplasm.